Celanese Corp., US1510201049

Celanese Corp. stock reacts to Nutrinova stake sale and JV reshaping

Published on 09/02/2026 at 15:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Celanese Corp. stock is trading lower as investors digest the announced sale of an additional 19 percent Nutrinova joint-venture stake to Mitsui for USD 152 million and a modest dividend, while the specialty materials group continues to focus on deleveraging and portfolio reshaping.

Bauhaus-Poster in Primärfarben mit geometrischen Formen, dem Text CHEM und NYSE-Verweis — Celanese Corp. Bauhaus-Grafikposter mit großem CHEM-Sektor-Text geometrischen Primärfarben-Formen und kleinem NYSE-Kürzel US1510201049, Illustration mit AI erstellt.

Celanese Corp. stock (ISIN US1510201049) closed at 44.13 USD on September 1, 2026 on the New York Stock Exchange, leaving the chemical and specialty materials group valued in the mid single-digit billion USD range as investors weighed ongoing portfolio moves and capital returns according to market data compiled by a major financial portal. On September 1, 2026, the company also traded as an American depositary receipt accessible to investors in Europe alongside peers such as BASF and Covestro, underlining its relevance for cross-border portfolios.

Nutrinova stake sale supports deleveraging

According to an official press statement released on September 1, 2026, Celanese Corporation announced that it has signed a definitive agreement with Mitsui to sell an additional 19 percent stake in the Nutrinova food ingredients joint venture for total cash proceeds of approximately 152 million USD. The company stated that this ownership interest contributed roughly 4 million USD of equity earnings in 2025, which implies that the transaction values those earnings at about 38 times that historical contribution, providing a capital-efficient way to advance balance-sheet goals. Management emphasized that the deal forms part of its broader deleveraging plan while retaining an 11 percent interest in the Nutrinova business, allowing Celanese to continue participating in a leading food ingredients platform.

Market commentary from a financial news outlet on September 1, 2026 highlighted that the Nutrinova transaction follows earlier steps by Celanese to streamline its portfolio, suggesting that management is prioritizing businesses with higher strategic fit and scale. For investors, the key question is how quickly the 152 million USD in cash proceeds will translate into lower net debt or additional organic investment, especially given that the divested stake delivered modest earnings of 4 million USD in 2025 compared with the broader group.

Dividend and analyst expectations frame valuation

Dividend data for Celanese as of July 28, 2026 show that the company most recently paid a quarterly dividend of 0.03 USD per share, with an ex-dividend date of July 28, 2026 and a payment date of August 10, 2026 according to a dedicated dividend-tracking portal. Annualized, this payout corresponds to 0.12 USD per share, a relatively low cash return compared with historical levels and peers, which indicates that the board is currently reserving more free cash flow for deleveraging and strategic investments. The same source notes that Celanese maintains a regular quarterly dividend rhythm, giving income-oriented investors some visibility despite the modest amount.

On the valuation side, a research overview published on September 2, 2026 reports that the consensus analyst target price for Celanese stock stands around 63.71 USD per share, with the shares currently rated on average as a Hold. With the stock closing at 44.13 USD on September 1, 2026, this implies an upside of about 44 percent to the consensus target, suggesting that the market is discounting either cyclical risk or execution risk on portfolio measures relative to analysts. The same overview notes that the shares have declined approximately 1.3 percent over the past 12 months while the broader industry benchmark edged up about 0.9 percent, underscoring that Celanese has lagged its sector even as it undertakes restructuring moves.

Go deeper

More on Celanese Corp.

Background articles, regulatory news and detailed price data for Celanese Corp. are available in the company overview.

More articles on Celanese Corp.Investor Relations

Engineered materials remain core business

Celanese is best known for its engineered materials portfolio, including acetyl chain products and specialty polymers used in automotive, electronics and industrial applications. Company information available as of September 2, 2026 shows that these segments continue to account for the bulk of revenue and operating income, with food ingredients like Nutrinova representing a smaller but profitable contribution. Historical filings indicate that in earlier fiscal years, total company revenue reached several billion USD, with engineered materials driving a significant share, while the Nutrinova joint venture delivered single-digit million equity contributions such as the 4 million USD recorded in 2025, highlighting why management sees more value in monetizing the stake at 152 million USD than holding it for incremental earnings.

Celanese Corp. stock price snapshot

Celanese Corp. stock closed at 44.13 USD on September 1, 2026 on the New York Stock Exchange, unchanged in after-hours trading according to a major financial portal, after falling 1.35 USD or 2.97 percent during the regular session. With the current price in the mid-40 USD range and a consensus target of 63.71 USD, the shares are trading clearly below analyst expectations, even as the company executes on its Nutrinova divestment and maintains a modest but continuing dividend stream.